Tacrolimus prolonged release
Phase 2
AstellasTacrolimus prolonged release is one of 2 therapeutic programs targeting Transplantation. It is currently in Phase 2.
1
Indications
1
Total Trials
0
Active Trials
1
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
1 competitor in Transplantation
#DrugCompanyPhaseTrials
1Prograf
VVeloxis Pharmaceuticals
Phase 2
Tacrolimus prolonged release
AstellasPhase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Transplantation1 trial
Sources
References
- [1]
- [2]
- [3]